Author: Ken Dropiewski

Worldwide Leader in Cerebrovascular Imaging Unveils Expansion of First Comprehensive Stroke Analytics Solution

New RapidAI Insights Improves Hospitals’ Understanding of Their Stroke Businesses, as Well as Patient Workflow and Outcomes MENLO PARK, Calif.–(BUSINESS WIRE)–RapidAI, the leader in advanced cerebrovascular imaging, today announced the expansion of RapidAI Insights, a unique analytics solution that uses Rapid® scan, treatment, and outcome data to enable hospitals and […]

United Therapeutics Corporation Reports First Quarter 2021 Financial Results

Tyvaso® (treprostinil) Inhalation Solution approved for pulmonary hypertension associated with interstitial lung disease (PH-ILD) Tyvaso DPI™ New Drug Application (NDA) submitted to U.S. Food and Drug Administration TETON study of Tyvaso in idiopathic pulmonary fibrosis (IPF) expected to enroll its first patients in the second quarter of 2021 SILVER SPRING, […]

Ionis reports first quarter 2021 financial results and recent business achievements

On track to achieve 2021 guidance Webcast today, May 5, 2021, at 11:30 a.m. Eastern Time CARLSBAD, Calif., May 5, 2021 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported its financial results for the first quarter of 2021 and recent business highlights. “In the first quarter, we took important steps to maximize […]

TransMedics Reports First Quarter 2021 Financial Results

ANDOVER, Mass., May 4, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2021. Recent Highlights Net revenue of $7.1 million in the first quarter of 2021, […]

ESPERION Reports First Quarter 2021 Financial Results and Provides Company Update

– U.S. Product Revenue of $6.4 Million, Growing Demand Offset by Lower Net Price – – Prescriptions Grew 46% Sequentially; More Than 35,000 Patients now on NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets – – Secured Major Medicare Part D Contract Covering Approximately 8.5 Million Lives – – […]

Aziyo Biologics Reports First Quarter 2021 Financial Results and Increases 2021 Revenue Guidance

SILVER SPRING, Md., May 04, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three months ended March 31, 2021. Recent Highlights Recorded […]

HeartFlow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease

REDWOOD CITY, Calif. & NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, and MedAxiom, an American College of Cardiology (ACC) company whose mission is to transform cardiovascular care and improve heart health, announced today a collaboration to improve cardiovascular care for patients with coronary artery disease (CAD). The […]

Verve Therapeutics Appoints Industry Leader Sheila Mikhail to its Board of Directors

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sheila Mikhail, J.D., MBA, chief executive officer and co-founder of Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, has joined the company’s board of […]